CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Uphealth Inc   (NYSE: UPH)
Other Ticker:  
 
 

UPH's Revenue Growth by Quarter and Year

Uphealth Inc 's Revenue results by quarter and year

Download as CSV




UPH Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December - 18.32 41.90 31.88
3rd Quarter September - 32.62 35.30 0.00
2nd Quarter June - 36.98 42.84 0.00
1st Quarter March 0.00 41.68 49.07 0.00
FY   0.00 129.60 169.11 31.88





UPH Revenue first quarter 2024 Y/Y Growth Comment
Uphealth Inc in the first quarter 2024 recorded of $ 0.00 millions.

Looking into first quarter 2024 results within Medical Equipment & Supplies industry 128 other companies have achieved higher Revenue growth. While Uphealth Inc ' s Revenue meltdown of -100% ranks overall at the positon no. 2423 in the first quarter 2024.


UPH Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - -56.28 % 31.43 % -
3rd Quarter September - -7.59 % - -
2nd Quarter June - -13.68 % - -
1st Quarter March - -15.06 % - -
FY   - -23.36 % 430.46 % -

Financial Statements
Uphealth Inc 's first quarter 2024 Revenue $ 0.00 millions UPH's Income Statement
Uphealth Inc 's first quarter 2023 Revenue $ 41.68 millions Quarterly UPH's Income Statement


UPH Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - -43.84 % 18.7 % -
3rd Quarter September - -11.79 % -17.6 % -
2nd Quarter June - -11.28 % -12.7 % -
1st Quarter March - -0.53 % 53.92 % -
FY (Year on Year)   - -23.36 % 430.46 % -


Back to UPH Growth rate Comparisons >> Back to UPH Growth rate Comparisons >>


Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #129
Healthcare Sector #381
Overall #2423

Revenue Y/Y Growth Statistics
High Average Low
-3.72 % -13.55 % -23.37 %
(Sep 30 2023)   (Dec 31 2023)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #129
Healthcare Sector #381
Overall #2423
Revenue Y/Y Growth Statistics
High Average Low
-3.72 % -13.55 % -23.37 %
(Sep 30 2023)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Uphealth Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


UPH's I. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Uphealth Inc come out even worse considering the 18.32 millions a quarter before.

Within Medical Equipment & Supplies industry Uphealth Inc achieved highest sequential Revenue growth. While Uphealth Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


UPH's I. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Uphealth Inc come out even worse considering the 18.32 millions a quarter before.

Within Medical Equipment & Supplies industry Uphealth Inc achieved highest sequential Revenue growth. While Uphealth Inc 's Revenue growth quarter on quarter, overall rank is .


Uphealth Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 0.00 $ 129.60 $ 153.17 $ 155.86 $ 161.72
Y / Y Revenue Growth (TTM) - -23.37 % -3.72 % - -
Year on Year Revenue Growth Overall Ranking # 2375 # 1955 # 2201 # 0 # 0
Seqeuential Revenue Change (TTM) - -15.39 % -1.72 % -3.63 % -4.37 %
Seq. Revenue Growth (TTM) Overall Ranking # 2423 # 1229 # 1656 # 1277 # 554


Cumulative Revenue growth Comment
Uphealth Inc realized trailing twelve months of $ 0 millions, in the Mar 31 2024, compare to Revenue of $ 162 millions a year ago.

In the Healthcare sector 370 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1955 to 2375.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 129
Healthcare Sector # 371
Overall # 2375

Revenue TTM Y/Y Growth Statistics
High Average Low
-3.72 %
 -13.55 %
-23.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 129
Sector # 381
S&P 500 # 2423
Cumulative Revenue growth Comment
Uphealth Inc realized trailing twelve months of $ 0 millions, in the Mar 31 2024, compare to Revenue of $ 162 millions a year ago.

In the Healthcare sector 370 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1955 to 2375.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 129
Healthcare Sector # 371
Overall # 2375

Revenue TTM Y/Y Growth Statistics
High Average Low
-3.72 %
-13.55 %
-23.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 129
Sector # 381
S&P 500 # 2423




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
UPH's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue meltdown for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Collegium Pharmaceutical inc -0.21%$ -0.215 millions
Mettler Toledo International Inc-0.30%$ -0.300 millions
3m Company-0.35%$ -0.349 millions
Icu Medical Inc-0.42%$ -0.423 millions
Lifeloc Technologies Inc -0.51%$ -0.513 millions
Regeneron Pharmaceuticals Inc -0.54%$ -0.541 millions
Envista Holdings Corporation-0.62%$ -0.622 millions
Orgenesis Inc-0.70%$ -0.704 millions
T2 Biosystems Inc -0.82%$ -0.818 millions
Vyne Therapeutics Inc -1.01%$ -1.010 millions
Enhabit Inc -1.02%$ -1.018 millions
Ge Healthcare Technologies Inc -1.50%$ -1.502 millions
Baxter International Inc -1.56%$ -1.562 millions
Y mabs Therapeutics inc -1.58%$ -1.580 millions
Pacific Biosciences Of California Inc -1.59%$ -1.589 millions
Cartesian Therapeutics Inc -1.65%$ -1.650 millions
Viatris Inc -1.76%$ -1.762 millions
Sight Sciences Inc -1.87%$ -1.870 millions
Opus Genetics Inc -2.17%$ -2.173 millions
Vaso Corporation-2.51%$ -2.513 millions
Dentsply Sirona Inc -2.56%$ -2.556 millions
Alpha Pro Tech Ltd -2.78%$ -2.775 millions
Prestige Consumer Healthcare Inc -2.82%$ -2.817 millions
West Pharmaceutical Services Inc -2.99%$ -2.986 millions
Wave Life Sciences Ltd -3.02%$ -3.024 millions
Fulgent Genetics Inc -3.12%$ -3.119 millions
Integra Lifesciences Holdings Corp-3.14%$ -3.144 millions
Accelerate Diagnostics Inc -3.17%$ -3.165 millions
National Research Corporation-3.18%$ -3.180 millions
Catheter Precision Inc -3.53%$ -3.529 millions


About Uphealth Inc Revenue Growth Rates (UPH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Uphealth Inc (CIK 1770141).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001770141-24-000078
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Uphealth Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.